Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | ACP3 | P15309 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.42 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3858791 | 1.00 | GAA (0.65) | GAACYP2C9MEN1MAPTKMT2A | |
| SCHEMBL28973546 | 1.00 | GAA (0.65) | GAACYP2C9MEN1MAPTKMT2A | |
| Acetic Acid SCHEMBL28093893 | 0.92 | GAA (0.57) | GAACYP2C9MEN1MAPTKMT2A | |
| SCHEMBL8805155 | 0.87 | GAA (0.56) | GAACYP2C9MEN1MAPTKMT2A | |
| SCHEMBL30598699 | 0.87 | GAA (0.61) | GAACYP2C9MEN1MAPTKMT2A | |
| SCHEMBL598722 | 0.85 | GAA (0.57) | GAACYP2C9MEN1MAPTKMT2A | |
| SCHEMBL8496291 | 0.85 | GAA (0.54) | GAACYP2C9MEN1MAPTKMT2A | |
| SCHEMBL21247060 | 0.85 | GAA (0.50) | GAACYP2C9MEN1MAPTKMT2A | |
| SCHEMBL11603883 | 0.84 | ACP3 (0.55) | GAACYP2C9MEN1KMT2AACP3 | |
| SCHEMBL8497190 | 0.84 | CYP2C9 (0.49) | GAACYP2C9MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113402770-B | Method for degrading, recycling and reusing polyurethane | 上海鹤城高分子科技有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-112517060-B | Catalyst, application and synthesis method of 4-hydroxycoumarin derivative | 山东农业大学 | 2022-03-25 | — | — | CN | claimed |
| CN-113402770-A | Method for degrading, recycling and reusing polyurethane | 上海鹤城高分子科技有限公司 | 2021-09-17 | — | — | CN | claimed |
| EP-3254860-B1 | RECORDING MATERIAL AND RECORDING SHEET | NIPPON SODA CO (JP) | 2020-11-04 | — | — | EP | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-20020137816-A1 | Phase change inks | XEROX CORPORATION | 2002-09-26 | — | — | US | claimed |
| EP-0677076-B1 | DIARYL CARBINOL METATHESIS CATALYSTS | SHELL OIL CO (US) | 1997-04-16 | — | — | EP | claimed |
| EP-0677076-A1 | DIARYL CARBINOL METATHESIS CATALYSTS. | SHELL OIL CO (US) | 1995-10-18 | — | — | EP | claimed |
| WO-1994015989-A1 | DIARYL CARBINOL METATHESIS CATALYSTS | SHELL OIL COMPANY (US) | 1994-07-21 | — | — | WO | claimed |
| US-5276118-A | Metal complex | SHELL OIL COMPANY (US) | 1994-01-04 | — | — | US | claimed |
| US-3968147-A | COORDINATION CATALYST | MONSANTO COMPANY (US) | 1976-07-06 | — | — | US | claimed |
| WO-2024213709-A1 | COMPOSITIONS FOR LITHIUM-ION BATTERY ELECTRODES, ELECTRODES AND BATTERIES USING SAID COMPOSITIONS | ARKEMA FRANCE (FR) | 2024-10-17 | — | — | WO | disclosed |
| EP-4447148-A1 | COMPOSITIONS FOR LITHIUM-ION BATTERY ELECTRODES, ELECTRODES AND BATTERIES USING SAID COMPOSITIONS | ARKEMA FRANCE (FR) | 2024-10-16 | — | — | EP | disclosed |
| US-20240336645-A1 | METALLOCENE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | PETROCHINA COMPANY LIMITED (CN) | 2024-10-10 | — | — | US | disclosed |
| EP-4406978-A1 | METALLOCENE COMPOUND, PREPARATION METHOD AND USE | PetroChina Company Limited (CN) | 2024-07-31 | — | — | EP | disclosed |
| EP-0350309-B1 | PIPERIDINE DERIVATIVES | Pfizer Limited (GB) | 1992-11-11 | — | — | EP | disclosed |
| US-5089505-A | Anticholinergic agents | PFIZER INC. (US) | 1992-02-18 | — | — | US | disclosed |
| CN-1039415-A | New 1, the preparation method of 3-3-disubstituted piperidine derivatives | PFIZER (GB) | 1990-02-07 | — | — | CN | disclosed |
| EP-0350309-A1 | Piperidine derivatives | Pfizer Limited (GB) | 1990-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336645-A1 | METALLOCENE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | CPNE4, ZC3HAV1L, ZRANB2 | GAA 3850/4885CYP2C9 2791/4885MEN1 1148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.